Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Cash from Operations (2019 - 2025)

Keros Therapeutics filings provide 7 years of Cash from Operations readings, the most recent being 27292000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 40.68% to 27292000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 107505000.0, a 166.83% increase, with the full-year FY2025 number at 107505000.0, up 166.83% from a year prior.
  • Cash from Operations hit 27292000.0 in Q4 2025 for Keros Therapeutics, down from 3249000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 161171000.0 in Q1 2025 to a low of 46008000.0 in Q4 2024.
  • Median Cash from Operations over the past 5 years was 25030500.0 (2022), compared with a mean of 15504100.0.
  • Biggest five-year swings in Cash from Operations: plummeted 2299.09% in 2023 and later soared 461.69% in 2025.
  • Keros Therapeutics' Cash from Operations stood at 19565000.0 in 2021, then decreased by 9.6% to 21443000.0 in 2022, then decreased by 18.73% to 25459000.0 in 2023, then crashed by 80.71% to 46008000.0 in 2024, then skyrocketed by 40.68% to 27292000.0 in 2025.
  • The last three reported values for Cash from Operations were 27292000.0 (Q4 2025), 3249000.0 (Q3 2025), and 29623000.0 (Q2 2025) per Business Quant data.